| In millions, except per share items | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Product sales | 14.9 | 8.3 | 2.2 | 1.5 | 2.7 | 2.3 | |
| Total revenues [+] | 14.6 | 4.2 | 2.2 | 1.5 | 2.7 | 2.3 | 0.6 |
| Products | 14.9 | 8.3 | 2.2 | 1.5 | 2.7 | 2.3 | |
| Grants | -0.4 | -4.0 | | | | | |
| Revenue growth [+] | 245.1% | 94.6% | 40.8% | -42.1% | 16.3% | 309.0% | |
| Product sales | 80.6% | 280.9% | 40.8% | -42.1% | 16.3% | | |
| Cost of goods sold | 22.3 | 13.7 | 2.6 | 6.0 | 2.7 | 1.7 | 0.8 |
| Gross profit | -7.7 | -9.4 | -0.4 | -4.5 | 0.0 | 0.5 | -0.3 |
| Gross margin | -53.1% | -223.4% | -20.3% | -291.7% | -0.9% | 23.8% | -49.4% |
| Selling, general and administrative [+] | 14.3 | 12.4 | 14.6 | 15.1 | 14.5 | 15.9 | 9.2 |
| Sales and marketing | 1.9 | 2.9 | 4.0 | 4.5 | 4.7 | 4.2 | 2.5 |
| General and administrative | 12.4 | 9.5 | 10.6 | 10.7 | 9.8 | 11.7 | 6.8 |
| Research and development | 5.5 | 7.2 | 20.3 | 15.2 | 16.6 | 20.4 | 16.7 |
| Equity in earnings | | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | |
| Other operating expenses | -0.2 | -4.2 | 1.0 | 0.2 | 0.3 | 0.0 | -53.1 |
| EBITDA [+] | -27.3 | -24.8 | -36.3 | -34.9 | -31.4 | -35.5 | 27.4 |
| EBITDA growth | 10.3% | -31.7% | 3.9% | 11.4% | -11.6% | -229.7% | |
| EBITDA margin | -187.5% | -586.5% | -1671.6% | -2264.6% | -1177.4% | -1549.6% | 4887.9% |
| Depreciation | 4.9 | 4.6 | 1.0 | 0.2 | 0.2 | 0.1 | 0.5 |
| EBITA | -32.2 | -29.4 | -37.3 | -35.2 | -31.5 | -35.6 | 26.9 |
| EBITA margin | -221.0% | -696.1% | -1718.2% | -2278.2% | -1183.5% | -1553.1% | 4794.6% |
| Amortization of intangibles | 0.2 | 0.2 | 0.1 | 0.1 | 1.0 | 2.0 | |
| EBIT [+] | -32.4 | -29.6 | -37.4 | -35.2 | -32.5 | -37.6 | 26.9 |
| EBIT growth | 9.5% | -20.7% | 6.2% | 8.2% | -13.5% | -240.1% | |
| EBIT margin | -222.4% | -701.1% | -1721.4% | -2281.5% | -1221.1% | -1641.9% | 4794.6% |
| Non-recurring items [+] | 77.6 | | 1.1 | | 8.6 | 1.2 | |
| Asset impairment | 77.6 | | 1.1 | | 8.6 | 1.2 | |
| Other income (expense), net [+] | 7.9 | 1.3 | -2.6 | -12.1 | 69.0 | 78.3 | 3.9 |
| Amortization of financing costs and debt discount | 2.6 | 3.3 | 1.1 | 0.3 | 0.2 | 0.1 | |
| Gain (loss) on debt retirement | -0.7 | | | 0.2 | -0.3 | | |
| Gain (loss) on foreign currency transactions | 0.2 | -0.2 | 1.0 | 0.2 | 0.3 | 0.0 | |
| Other | | | | 0.3 | 0.2 | 0.1 | |
| Pre-tax income | -102.1 | -28.3 | -41.2 | -47.3 | 27.8 | 39.5 | 30.7 |
| Income taxes | 0.1 | 0.0 | 0.0 | 0.1 | -0.1 | -0.1 | -0.1 |
| Tax rate | | | 0.0% | | | | |
| Minority interest | -4.0 | -5.9 | -3.9 | -0.9 | 0.6 | 0.2 | 0.2 |
| Net income | -98.2 | -22.5 | -37.2 | -46.5 | 27.4 | 39.4 | 30.9 |
| Net margin | -673.0% | -531.9% | -1713.9% | -3011.8% | 1026.3% | 1717.4% | 5506.9% |
| |
| Basic EPS [+] | ($2.34) | ($0.78) | ($1.52) | ($2.32) | $1.75 | $3.82 | $3.92 |
| Growth | 198.4% | -48.4% | -34.6% | -232.3% | -54.1% | -2.6% | |
| Diluted EPS [+] | ($2.34) | ($0.78) | ($1.52) | ($2.32) | $1.75 | $3.82 | $3.92 |
| Growth | 198.4% | -48.4% | -34.6% | -232.3% | -54.1% | -2.6% | |
| |
| Shares outstanding (basic) [+] | 41.9 | 28.7 | 24.5 | 20.0 | 15.6 | 10.3 | 7.9 |
| Growth | 46.3% | 17.0% | 22.4% | 28.4% | 51.4% | 30.9% | |
| Shares outstanding (diluted) [+] | 41.9 | 28.7 | 24.5 | 20.0 | 15.6 | 10.3 | 7.9 |
| Growth | 46.3% | 17.0% | 22.4% | 28.4% | 51.4% | 30.9% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |